Manufacturers Life Insurance Company, The Kymera Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 128,267 shares of KYMR stock, worth $5.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

128,267

Previous 130,077 1.39%

Holding current value

$5.39 Million

Previous $3.88 Million 56.36%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$30.16 - $52.4 $54,589 - $94,844	-1,810 Reduced 1.39%	128,267 $6.07 Million
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $457,302 - $603,914	15,320 Added 13.35%	130,077 $3.88 Million
Q1 2024 May 14, 2024	BUY	$22.9 - $43.57 $336,263 - $639,781	14,684 Added 14.67%	114,757 $4.61 Million
Q4 2023 Feb 13, 2024	BUY	$10.97 - $26.84 $253,330 - $619,816	23,093 Added 30.0%	100,073 $2.55 Million
Q3 2023 Nov 15, 2023	SELL	$13.9 - $23.88 $61,299 - $105,310	-4,410 Reduced 5.42%	76,980 $1.07 Million
Q2 2023 Aug 11, 2023	BUY	$22.4 - $34.92 $367,449 - $572,827	16,404 Added 25.24%	81,390 $1.87 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $272,122 - $424,506	10,955 Added 16.86%	75,941 $2.25 Million
Q4 2022 Aug 11, 2023	SELL	$19.57 - $30.92 $2,407 - $3,803	-123 Reduced 0.19%	64,986 $1.62 Million
Q4 2022 Feb 13, 2023	SELL	$19.57 - $30.92 $2,407 - $3,803	-123 Reduced 0.19%	64,986 $1.62 Million
Q3 2022 Aug 11, 2023	SELL	$20.91 - $34.27 $14,971 - $24,537	-716 Reduced 1.09%	65,109 $1.42 Million
Q3 2022 Nov 03, 2022	SELL	$20.91 - $34.27 $14,971 - $24,537	-716 Reduced 1.09%	65,109 $1.43 Million
Q2 2022 Aug 11, 2023	BUY	$14.13 - $42.55 $62,341 - $187,730	4,412 Added 7.18%	65,825 $1.3 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $62,341 - $187,730	4,412 Added 7.18%	65,825 $1.33 Million
Q1 2022 Aug 11, 2023	SELL	$35.3 - $64.68 $512,838 - $939,671	-14,528 Reduced 19.13%	61,413 $2.6 Million
Q1 2022 May 20, 2022	BUY	$35.3 - $64.68 $1.54 Million - $2.82 Million	43,674 Added 246.2%	61,413 $2.56 Million
Q4 2021 Feb 16, 2022	BUY	$49.91 - $65.56 $21,111 - $27,731	423 Added 2.44%	17,739 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $55,017 - $76,725	1,151 Added 7.12%	17,316 $1.02 Million
Q2 2021 Aug 12, 2021	BUY	$31.08 - $51.95 $312,385 - $522,149	10,051 Added 164.39%	16,165 $784,000
Q1 2021 May 03, 2021	BUY	$35.64 - $85.46 $1,746 - $4,187	49 Added 0.81%	6,114 $238,000
Q4 2020 Feb 12, 2021	BUY	$28.07 - $87.83 $170,244 - $532,688	6,065 New	6,065 $376,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Kymera Therapeutics, Inc. Transaction History